Study Comparing Treatment With Alluzience vs Reconstituted Toxin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Phase IV, open-label, randomized, interventional, two-armed, multi-centre study to investigate subject treatment perception and Investigator treatment experience when using Alluzience or vacuum-dried botulinum neurotoxin type A (powder BoNT-A) for treatment of glabellar lines (GL).
Epistemonikos ID: 0382e8ecfd136f450a8e12e7dec3204e4be2c5b2
First added on: May 10, 2024